Garrood T - Search Results

1

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.

Kamperidis P, Kamalati T, Ferrari M, Jones M, Garrood T, Smith MD, Diez-Posada S, Hughes C, Finucane C, Mather S, Nissim A, George AJ, Pitzalis C. Kamperidis P, et al. Among authors: garrood t. Arthritis Rheum. 2011 Dec;63(12):3758-67. doi: 10.1002/art.30650. Arthritis Rheum. 2011. PMID: 21953304 Free article.

2

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

Choy EH, Isenberg DA, Garrood T, Farrow S, Ioannou Y, Bird H, Cheung N, Williams B, Hazleman B, Price R, Yoshizaki K, Nishimoto N, Kishimoto T, Panayi GS. Choy EH, et al. Among authors: garrood t. Arthritis Rheum. 2002 Dec;46(12):3143-50. doi: 10.1002/art.10623. Arthritis Rheum. 2002. PMID: 12483717 Free article. Clinical Trial.

3

Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways.

Garrood T, Lee L, Pitzalis C. Garrood T, et al. Rheumatology (Oxford). 2006 Mar;45(3):250-60. doi: 10.1093/rheumatology/kei207. Epub 2005 Nov 30. Rheumatology (Oxford). 2006. PMID: 16319101 Review. No abstract available.

4

Targeting the inflamed synovium: the quest for specificity.

Garrood T, Pitzalis C. Garrood T, et al. Arthritis Rheum. 2006 Apr;54(4):1055-60. doi: 10.1002/art.21720. Arthritis Rheum. 2006. PMID: 16575837 Free article. No abstract available.

5

From ubiquitous antigens to joint-specific inflammation: could local vascular permeability be the missing link?

Pitzalis C, Garrood T. Pitzalis C, et al. Among authors: garrood t. Trends Immunol. 2006 Jul;27(7):299-302. doi: 10.1016/j.it.2006.05.005. Epub 2006 May 30. Trends Immunol. 2006. PMID: 16731042

6

In vivo phage display selection in the human/SCID mouse chimera model for defining synovial specific determinants.

Lee L, Garrood T, Pitzalis C. Lee L, et al. Among authors: garrood t. Methods Mol Med. 2007;136:369-94. doi: 10.1007/978-1-59745-402-5_26. Methods Mol Med. 2007. PMID: 17983161

7

A novel model for the pre-clinical imaging of inflamed human synovial vasculature.

Garrood T, Blades M, Haskard DO, Mather S, Pitzalis C. Garrood T, et al. Rheumatology (Oxford). 2009 Aug;48(8):926-31. doi: 10.1093/rheumatology/kep117. Epub 2009 Jun 2. Rheumatology (Oxford). 2009. PMID: 19491304

8

The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life.

Scott IC, Ibrahim F, Panayi G, Cope AP, Garrood T, Vincent A, Scott DL, Kirkham B; TITRATE Programme Investigators. Scott IC, et al. Among authors: garrood t. Semin Arthritis Rheum. 2019 Aug;49(1):20-26. doi: 10.1016/j.semarthrit.2018.12.006. Epub 2018 Dec 28. Semin Arthritis Rheum. 2019. PMID: 30685064

9

Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression.

Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW. Menon B, et al. Among authors: garrood t. Arthritis Rheumatol. 2014 May;66(5):1272-81. doi: 10.1002/art.38376. Arthritis Rheumatol. 2014. PMID: 24470327 Free PMC article.

10

Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis.

Garrood T, Scott DL. Garrood T, et al. BioDrugs. 2001;15(8):543-61. doi: 10.2165/00063030-200115080-00006. BioDrugs. 2001. PMID: 11543695 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page